Preparation and application of anti-HBx/anti-CD3 bispecific monoclonal antibody (BsAb) retargeting effector cells for lysis of human hepatoma xenografts in nude mice

Oncology Reports

Volumn 3, Issue 4, 1996, Pages 637-644

  Liao, Yong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

apoptosis; bispecific monoclonal antibody; effector cells; HBxAg; hepatoma; in situ end labeling (ISEL)

Indexed keywords

CANCER ANTIBODY; DNA; HEPATITIS B ANTIBODY; HEPATITIS B ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD3;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GRAFT; CELL FUSION; CONTROLLED STUDY; CYTOLYSIS; EFFECTOR CELL; FLUORESCENCE ACTIVATED CELL SORTER; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HYBRID; HYBRIDOMA; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL;

EID: 0029942283     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.3.4.637     Document Type: Article

References (2)

1. Tang ZY: Small hcpatocellular carcinoma: past, present and future. Chin Med J 109: 21-24, 1996.
2. Pisiani P, Parkin DM and Ferly J: Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 55: 891-963, 1993.